AnandChidambaramNarayananMD

Lipid Metabolism

Endocrinologist

Dr. Narayanan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1020 29th St. Ste 270
Sacramento, CA 95816
Phone+1 916-455-3700

Fax+1 916-503-7568

University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2021 - 2023
Kaiser Permanente Northern California (San Francisco)Residency, Internal Medicine, 2018 - 2021
University of California, Davis, School of MedicineClass of 2018, MD

PubMed

25 citations
Analysis of Worsening Heart Failure Events in an Integrated Health Care System.
Andrew P Ambrosy, Rishi V Parikh, Sue Hee Sung, Thida C Tan, Anand Narayanan
Journal of the American College of Cardiology. 2022-07-12
25 citations
A Natural Language Processing-Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System.
Andrew P. Ambrosy, Rishi V. Parikh, Sue Hee Sung, Anand Narayanan, Rajeev Masson
JAMA Network Open. 2021-11-01
2 citations
Management of Spontaneous Liver Hematoma in Ehlers-Danlos Syndrome Type IV: A Case Report.
Brandon Imp, Samuel Mannarino, Anand Narayanan
The Permanente Journal. 2020-11-01

Books/Book Chapters

Current Medical Diagnosis and Treatment
Chapter: Endocrine Disorders
Page 1099 - 1194Paul Fitzgerald, MD; Anand Narayanan, MDEditors: Lange Medical Publications.McGraw Hill2023

Abstracts/Posters

A Unicorn with Double Horns - Metastatic Paraganglioma in a Patient with Beckwith-Wiedemann Syndrome and Hereditary Paraganglioma Syndrome IV
Narayanan A, Soe M, Wheeler AL, Fitzgerald PA, Journal of the Endocrine Society, 5/8/2020

Daniel T. O’Connor, MD Memorial Research GrantUC Davis School of Medicine2016–2017

Research Fellow and Sub-Investigator at UCSF/VA Dept of EndocrinologyI worked on the Novel Combination Therapy for Osteoporosis in Men (NCT03994172) phase IV clinical trial investigating combination therapy with Forteo (FDA-approved for osteoporosis) and Sensipar (FDA-approved for hyperparathyroidism), to evaluate a potential synergy on improving bone quality.2022 - 2023